Dan Cao
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 36
- Pancreatic and Hepatic Oncology Research 13
- Colorectal Cancer Treatments and Studies 8
- Cancer Cells and Metastasis 7
- Co-authors
- Hongyang Wang (12 shared papers)Mengchao Wu (6 shared papers)Liang V. Tang (4 shared papers)Wen K. Yang (3 shared papers)Linna Guo (6 shared papers)Le‐Xing Yu (3 shared papers)Hongfeng Gou (8 shared papers)Shanhua Tang (3 shared papers)
- Journals
- Frontiers in Oncology (8 papers)Medical Oncology (6 papers)BMC Cancer (4 papers)OncoTargets and Therapy (4 papers)Journal of Hepatology (3 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Dan Cao
100 papers receiving 3k citations
Dan Cao's Hit Papers
Peers
Comparison fields: 5 of 94
- Cancer Research 550
- Hepatology 258
- Oncology 650
- Molecular Biology 1.1k
- Cell Biology 93
Countries citing papers authored by Dan Cao
This map shows the geographic impact of Dan Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Cao more than expected).
Fields of papers citing papers by Dan Cao
This network shows the impact of papers produced by Dan Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Cao. The network helps show where Dan Cao may publish in the future.
Co-authors
The 25 scholars most cited alongside Dan Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer Hit paper breakdown → | 2018 | 818 |
| 2 | 2009 | 186 | |
| 3 | 2014 | 160 | |
| 4 | 2011 | 136 | |
| 5 | 2017 | 106 | |
| 6 | 2016 | 98 | |
| 7 | 2018 | 88 | |
| 8 | 2011 | 78 | |
| 9 | 2014 | 75 | |
| 10 | 2010 | 66 | |
| 11 | 2016 | 65 | |
| 12 | 2016 | 64 | |
| 13 | 2011 | 51 | |
| 14 | 2016 | 51 | |
| 15 | 2016 | 50 | |
| 16 | 2010 | 49 | |
| 17 | 2013 | 40 | |
| 18 | 2011 | 39 | |
| 19 | 2017 | 39 | |
| 20 | 2022 | 39 |
About Dan Cao
Dan Cao is a scholar working on Oncology, Cancer Research, Hepatology, Epidemiology and Pulmonary and Respiratory Medicine, having authored 105 papers that have together received 3k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (13 papers), Colorectal Cancer Treatments and Studies (8 papers), Cancer Cells and Metastasis (7 papers), Neuroendocrine Tumor Research Advances (7 papers), Gastric Cancer Management and Outcomes (6 papers), Angiogenesis and VEGF in Cancer (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Gastrointestinal Tumor Research and Treatment (4 papers). The work is most often cited by research in Cancer Research (550 citations), Hepatology (258 citations), Oncology (650 citations), Molecular Biology (1.1k citations) and Cell Biology (93 citations). Dan Cao has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Hongyang Wang, Mengchao Wu, Liang V. Tang, Wen K. Yang, Linna Guo, Le‐Xing Yu, Hongfeng Gou, Shanhua Tang, Guishuai Lv and Hongwei Lv. Their work appears in journals such as Frontiers in Oncology, Medical Oncology, BMC Cancer, OncoTargets and Therapy and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.